The integration of artificial intelligence (AI) into drug discovery is revolutionizing pharmaceutical research by providing sophisticated tools for understanding and predicting complex biological ...

Activating the glucagon-like peptide 1 receptor (GLP-1R) is the mechanism of action of most drugs currently used to treat ...

Amphista Therapeutics (“the Company” or “Amphista”), a leader in next generation targeted protein degradation (TPD), announced today that it has published data in the journal Nature Communications ...

MariTide is now progressing into phase 3 trials, with a focus on its long-term safety and efficacy. Amgen expects to apply ...

New research suggests that psychedelic drugs may work by strengthening specific brain connections linked to memory and cognition.

It has long been known that bacterial pathogens are becoming increasingly resistant to antibiotics. However, common ...

Given the critical importance of endocytosis detection in ADC research and development, ACROBiosystems has designed an ...

While anti-VEGF therapies remain the current standard of care, many DME patients experience suboptimal responses due to ...

The company is dropping its social anxiety disorder program but will still test the molecule in post-traumatic stress ...

Nuvectis Pharma, Inc. (NASDAQ: NVCT), a clinical stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical ...

There has been an endless “war” between pathogen organisms armed with the ability to establish new, genetically based ...